ABVC BioPharma (ABVC) SEC Filings & 10K Form

$1.09
+0.03 (+2.82%)
(As of 02:39 PM ET)

Recent ABVC BioPharma SEC Filings

DateFilerForm TypeView
05/09/2024
8:27 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
04/25/2024
1:38 PM
ABVC BioPharma (Filer)
Form POS AM
04/19/2024
4:26 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
1:47 PM
ABVC BioPharma (Filer)
Form 424B4
04/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
03/26/2024
7:35 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
ABVC BioPharma (Filer)
Form DEFA14A
03/22/2024
4:01 PM
ABVC BioPharma (Filer)
Form S-1/A
03/14/2024
11:08 AM
ABVC BioPharma (Filer)
Form DEFA14A
03/14/2024
10:33 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
8:04 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:14 PM
ABVC BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
3:32 PM
ABVC BioPharma (Filer)
Form 8-K/A
02/13/2024
6:59 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
02/09/2024
4:04 PM
ABVC BioPharma (Filer)
Form S-1/A
02/08/2024
8:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
4:01 PM
ABVC BioPharma (Filer)
Form 8-K/A
01/17/2024
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
ABVC BioPharma (Filer)
Form DEF 14A
12/15/2023
4:22 PM
ABVC BioPharma (Filer)
Form PRE 14A
11/20/2023
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
8:20 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
7:41 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
7:00 AM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/13/2023
8:01 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
7:30 AM
ABVC BioPharma (Filer)
Form 8-K/A
08/31/2023
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
7:33 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
3:30 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
7:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
8:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
8:01 AM
ABVC BioPharma (Filer)
Form 424B5
07/27/2023
8:14 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
8:02 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2023
4:00 PM
ABVC BioPharma (Filer)
Form 8-K/A
07/07/2023
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
4:13 PM
ABVC BioPharma (Filer)
Form DEF 14A
06/08/2023
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad)

While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.

Click to watch this device in action
06/08/2023
6:17 AM
ABVC BioPharma (Filer)
Form S-1/A
06/07/2023
9:48 AM
ABVC BioPharma (Filer)
Form S-1/A
05/22/2023
11:04 AM
ABVC BioPharma (Filer)
Form 424B3
05/22/2023
11:07 AM
ABVC BioPharma (Filer)
Form 424B4
05/15/2023
3:01 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ABVC) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners